Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies

The recent marketing approval of several durable gene and cell therapies (2017-2020), together with observations that 7,000 monogenic indications and many cancers were potential targets, led to concern about the potential economic impact of such therapies on the US healthcare system. Using a Markov...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Colin M., Trusheim, Mark, Quinn, Casey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844867/
https://www.ncbi.nlm.nih.gov/pubmed/35198672
http://dx.doi.org/10.1016/j.dib.2022.107891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844867/
https://www.ncbi.nlm.nih.gov/pubmed/35198672
http://dx.doi.org/10.1016/j.dib.2022.107891

Ejemplares similares